Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): A comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T

Acta Radiologica

Volumn 53, Issue 5, 2012, Pages 485-493

  Song, Kyoung Doo ^a   Kim, Young Kon ^a   Lee, Won Jae ^a   Lee, Min Woo ^a   Park, Min Jung ^a   Hwang, Jiyoung ^a   Lee, Mi Hee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Diffusion weighted imaging; Gd EOB DTPA; Magnetic resonance imaging

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; B VALUE; CONTRAST TO NOISE RATIO; DIAGNOSTIC ACCURACY; DIAGNOSTIC CAPABILITIES; DIFFUSION WEIGHTED IMAGES; DIFFUSION WEIGHTED IMAGING; FOCAL LIVER LESIONS; GD-EOB-DTPA; HEPATIC LESIONS; KAPPA STATISTIC; KAPPA VALUES; LESION DETECTION; RECEIVER OPERATING CHARACTERISTICS; SIGNALTONOISE RATIO (SNR);

ANALOG TO DIGITAL CONVERSION; DIFFUSION; GADOLINIUM; MAGNETIC RESONANCE IMAGING; SIGNAL TO NOISE RATIO;

CHARACTERIZATION;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; GADOXETIC ACID;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SIGNAL-TO-NOISE RATIO;

EID: 84861860177     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2012.110437     Document Type: Article

References (22)

1. Brismar TB, Dahlstrom N, Edsborg N, et al. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers. Acta Radiol 2009;50:709-15
2. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT - a multicenter trial. J Comput Assist Tomogr 2006;30:345-54 (Pubitemid 43922248)
3. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005;234:468-78 (Pubitemid 40139918)
4. Jung G, Breuer J, Poll LW, et al. Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 2006;47:15-23 (Pubitemid 43177525)
5. Tanimoto A, Satoh Y, Yuasa Y, et al. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis. J Magn Reson Imaging 1997;7:120-4
6. Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67 (Pubitemid 26197732)
7. Stern W, Schick F, Kopp AF, et al. Dynamic MR imaging of liver metastases with Gd-EOB-DTPA. Acta Radiol 2000;41:255-62
8. Kim YK, Kwak HS, Kim CS, et al. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid. J Magn Reson Imaging 2009;30:437-43
9. Yamada K, Kubota H, Kizu O, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted images: evaluation of normal brain and infarcts. Stroke 2002;33:1799-802 (Pubitemid 34761064)
10. Choi JS, Kim MJ, Choi JY, et al. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 2010;20:1052-60
11. Choi SA, Lee SS, Jung IH, et al. The effect of gadoxetic acid enhancement on lesion detection and characterisation using T2 weighted imaging and diffusion weighted imaging of the liver. Br J Radiol 2012;85:29-36
12. Vandecaveye V, De Keyzer F, Verslype C, et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 2009;19:2456-66
13. Piana G, Trinquart L, Meskine N, et al. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 2011;55:126-32
14. Kim YK, Kim CS, Han YM, et al. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial? Clin Radiol 2011;66:489-96
15. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2
16. Holzapfel K, Bruegel M, Eiber M, et al. Characterization of small (
17. Beam CA. Analysis of clustered data in receiver operating characteristic studies. Stat Methods Med Res 1998;7:324-36 (Pubitemid 28559252)
18. Rinck P. Magnetic resonance in medicine. 4th edn. Berlin: Blackwell Science, 2001
19. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254:47-66
20. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006;239:122-30
21. Chandarana H, Taouli B. Diffusion-weighted MRI and liver metastases. Magn Reson Imaging Clin N Am 2010;18:451-64, x
22. Willinek WA, Gieseke J, Kukuk GM, et al. Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. Radiology 2010;256:966-75